Hot Stock on the Radar: Fibria Celulose S.A. (NYSE:FBR), Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX)

Fibria Celulose S.A. (NYSE:FBR)

The shares of Fibria Celulose S.A. (NYSE:FBR) started off the last trading session with the price of $19.23 while closing the day with the price of $18.95. The shares of Fibria Celulose S.A. (NYSE:FBR) Rise 0.64% with the Loss of -0.28 points.

The shares of Fibria Celulose S.A. (NYSE:FBR) traded with the day volume of 1.45 Million shares whereas its average trading volume is 1.55 Million.

While analyzing the past performance of the stock we can see that the shares of Fibria Celulose S.A. (NYSE:FBR) Gain 1.34% in the last week while rising 10.17% in the last month. Past quarter performance shows the green light with 29.35%. The semi-annual and annual performance shows 44.11% and 127.49% respectively.

Some critical values of the shares of Fibria Celulose S.A. (NYSE:FBR) to be discussed here are: the beta which shows the value at -0.08 while Average True Range of Fibria Celulose S.A. (NYSE:FBR) demonstrate the value at 0.6. The weekly and monthly volatility of the shares of Fibria Celulose S.A. (NYSE:FBR) are indicated at 2.49% and 3.15%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 67.34.

While studying the financial position of the shares of Fibria Celulose S.A. (NYSE:FBR), we can see that the Market capitalization of the company is at 10.47 Billion. The shares outstanding for the company is 552.42 Million and the shares float stands at 229.88 Million. The income of the company stand at 333.8 Million while the sales stand at 3.61 Billion.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 0.6, Price to Earnings or P/E is at 31.48, Price to Sales P/S show the value of 2.9, the Return on Asset ROA stood at 0.029 and the Return on Equity ROE depicted at 0.076 while Return on Investment ROI is at 0.056.


Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX)

Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) started its previous trading session at $6.56 and closed at $6.69 showing a Rise of 1.06 Percent.

The Company traded with an average Volume of 1.3 Million whereas, its Day Volume stood at 1.45 Million.

Looking at the performance of the stock, Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) Gain 8.6% in the last week in its shares price and 14.36% in the last month. Quarterly performance shows a green of 18.62 Percent while Semi-Annual and Annual performances shows a 1.06 and -40.27 percent respectively.

Beta for Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) stands at 2.56 while the ATR (average true range) is at 0.33. The Stock’s Weekly and Monthly Volatility is 6.10% and 6.14% respectively showing a RSI value of 65.79.

While studying the financial position of the shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), we can see that the Market capitalization of the company is at 470.11 Million. The shares outstanding for the company is 70.27 Million and the shares float stands at 69.85 Million.

The Company generated an income of -55600000 and the sales of 12.5 Million in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-0.79 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 37.61 respectively.

The Return on Assets stands at -0.315, ROE shows a value of -0.676 and ROI for Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) is 0.073 as of Trailing Twelve Months period.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Comment